Paper
0
Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
Authors
Marcin Wlodarski,Shinsuke Hirabayashi
Víctor Pastor,Jan Starý,Henrik Hasle,Riccardo Masetti,Michael Dworzak,Markus Schmugge,Marry Heuvel‐Eibrink,Marek Ussowicz,Barbara Moerloose,Albert Catalá,Owen Smith,Petr Sedláček,Arjan Lankester,Marco Zecca,Victoria Bordon,Susanne Matthes‐Martin,Jonas Abrahamsson,J. Kühl,Karl-Walter Sykora,Michael Albert,Bartlomiej Przychodzien,Jaroslaw Maciejewski,Stephan Schwarz,Gudrun Göhring,Brigitte Schlegelberger,Annámaria Cseh,Peter Noellke,Ayami Yoshimi,Franco Locatelli,Irith Baumann,Brigitte Strahm
+31 authors
,Charlotte NiemeyerJournal
Published
Dec 24, 2015
Show more
Save
Tip0
TipSave
Abstract
Key Points Germline GATA2 mutations account for 15% of advanced and 7% of all primary pediatric MDS and do not influence overall survival. The majority (72%) of adolescents with MDS and monosomy 7 carry an underlying GATA2 deficiency.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.